The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.

This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.

Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed ...

The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough Therapy designation for litifilimab (BIIB059) in clinical development by Biogen ...

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...

SAN ANTONIO — Distinguishing between the various forms of cutaneous lupus can be challenging, even for experienced clinicians. If a patient presents with a malar rash — also known as a butterfly rash ...

Many people with lupus have hair loss or thinning hair. Find out what you can do to manage hair loss and keep your hair as healthy as possible. Many people with lupus have skin problems, like rashes ...

There are a few to keep in mind.

Biogen BIIB announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, ...

Diseases such as lupus that cause rashes and other skin problems also can trigger migraine headaches, strokes and other serious neurological conditions, according to an article by Loyola University ...

Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon ...